[
  {
    "ts": null,
    "headline": "BlackRock Sustainable U.S. Value Equity Fund Q4 2024 Commentary",
    "summary": "BlackRock Sustainable U.S. Value Equity Fund posted returns of -4.18% (Institutional shares) and -4.19% (Investor A shares, without sales charge) for the fourth quarter of 2024.",
    "url": "https://finnhub.io/api/news?id=d345280ec967ca40f93c53253b3f1065ce60c4526c9df3c9943a90ae3000bd90",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742510100,
      "headline": "BlackRock Sustainable U.S. Value Equity Fund Q4 2024 Commentary",
      "id": 133295088,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1400960132/image_1400960132.jpg?io=getty-c-w1536",
      "related": "LH",
      "source": "SeekingAlpha",
      "summary": "BlackRock Sustainable U.S. Value Equity Fund posted returns of -4.18% (Institutional shares) and -4.19% (Investor A shares, without sales charge) for the fourth quarter of 2024.",
      "url": "https://finnhub.io/api/news?id=d345280ec967ca40f93c53253b3f1065ce60c4526c9df3c9943a90ae3000bd90"
    }
  },
  {
    "ts": null,
    "headline": "Labcorp Holdings Inc. stock underperforms Thursday when compared to competitors",
    "summary": "Labcorp Holdings Inc. stock underperforms Thursday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=bb92044e904d4a4f3458236342dfc481362ae926a5f485eb8773da4b20fa6e45",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742490420,
      "headline": "Labcorp Holdings Inc. stock underperforms Thursday when compared to competitors",
      "id": 133353907,
      "image": "",
      "related": "LH",
      "source": "MarketWatch",
      "summary": "Labcorp Holdings Inc. stock underperforms Thursday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=bb92044e904d4a4f3458236342dfc481362ae926a5f485eb8773da4b20fa6e45"
    }
  },
  {
    "ts": null,
    "headline": "Invesco Health Care Fund Q4 2024 Commentary",
    "summary": "Stock selection in life science tools & services, pharmaceuticals and distributors detracted from relative performance, as did an overweight in health care facilities.",
    "url": "https://finnhub.io/api/news?id=8f81827abb6ec00be306ef52a83e31acbe2c243bf3d6f7d992305822a81d2a8e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742461500,
      "headline": "Invesco Health Care Fund Q4 2024 Commentary",
      "id": 133273550,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2154850841/image_2154850841.jpg?io=getty-c-w1536",
      "related": "LH",
      "source": "SeekingAlpha",
      "summary": "Stock selection in life science tools & services, pharmaceuticals and distributors detracted from relative performance, as did an overweight in health care facilities.",
      "url": "https://finnhub.io/api/news?id=8f81827abb6ec00be306ef52a83e31acbe2c243bf3d6f7d992305822a81d2a8e"
    }
  }
]